Page last updated: 2024-08-21

pyrazines and Hepatitis C

pyrazines has been researched along with Hepatitis C in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Akagi, Y; Fujioka, S; Inaba, T; Ito, S; Kinoshita, W; Komoda, Y; Kondo, K; Maeda, K; Nakamura, H; Okuda, S; Tamatani, Y; Terui, T; Ukaji, Y	1
Abdurakhmanov, E; Belfrage, AK; Brandt, P; Danielson, UH; Gising, J; Kerblom, E; Neyts, J; Oshalim, A; Sandström, A; Skogh, A	1
Birkenbach, M; Constantinescu, S; Daller, JA; Gillespie, A; Karachristos, A; Lee, I; Leech, S; Sifontis, NM; Silva, P; Swami, A	1
Cho, SH; Choi, JY; Chon, CY; Han, JY; Jang, JJ; Jang, JW; Kim, SG; Kim, YM; Lee, DH; Lee, YS; Um, SH; Yu, E	1
Matsumori, A	1

Reviews

1 review(s) available for pyrazines and Hepatitis C

Article	Year
Cytokines in myocarditis and cardiomyopathies. Current opinion in cardiology, 1996, Volume: 11, Issue:3 Topics: Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Cytokines; Heart Injuries; Hepatitis C; Humans; Mice; Mice, Mutant Strains; Myocarditis; Pyrazines; Quinolines	1996

Trials

1 trial(s) available for pyrazines and Hepatitis C

Article	Year
Oltipraz therapy in patients with liver fibrosis or cirrhosis: a randomized, double-blind, placebo-controlled phase II trial. The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:5 Topics: Adult; Anticarcinogenic Agents; Biomarkers; Biopsy; Collagen; Double-Blind Method; Female; Hepatitis B; Hepatitis C; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Pyrazines; Thiones; Thiophenes; Transforming Growth Factor beta1	2011

Article

Year

Oltipraz therapy in patients with liver fibrosis or cirrhosis: a randomized, double-blind, placebo-controlled phase II trial.

The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:5

Topics: Adult; Anticarcinogenic Agents; Biomarkers; Biopsy; Collagen; Double-Blind Method; Female; Hepatitis B; Hepatitis C; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Pyrazines; Thiones; Thiophenes; Transforming Growth Factor beta1

2011

Other Studies

3 other study(ies) available for pyrazines and Hepatitis C

Article	Year
Orally bioavailable HCV NS5A inhibitors of unsymmetrical structural class. Bioorganic & medicinal chemistry letters, 2020, 09-01, Volume: 30, Issue:17 Topics: Administration, Oral; Antiviral Agents; Genotype; Hepacivirus; Hepatitis C; Humans; Mutation; Pargyline; Pyrazines; Structure-Activity Relationship; Viral Nonstructural Proteins; Virus Replication	2020
Discovery of pyrazinone based compounds that potently inhibit the drug-resistant enzyme variant R155K of the hepatitis C virus NS3 protease. Bioorganic & medicinal chemistry, 2016, 06-15, Volume: 24, Issue:12 Topics: Antiviral Agents; Drug Resistance, Viral; Hepacivirus; Hepatitis C; Humans; Molecular Docking Simulation; Point Mutation; Protease Inhibitors; Pyrazines; Viral Nonstructural Proteins	2016
Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line? Clinical transplants, 2009 Topics: B-Lymphocytes; Boronic Acids; Bortezomib; Creatinine; Follow-Up Studies; Graft Rejection; Hepatitis C; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulins, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Protease Inhibitors; Pyrazines; T-Lymphocytes	2009